We hope you will take a moment to read through Glickman Urological & Kidney Institute’s Year in Review publication. One of our greatest strengths as an institute is our propensity to innovate within urology and kidney medicine and across our diverse subspecialty areas. From developing new ways to screen for and treat genitourinary cancers and establishing new standards of care in outpatient and acute kidney care settings, to leveraging robotic and artificial intelligence platforms that improve and individualize care — we are always looking for better ways to serve our patients.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
A roundup of Cleveland Clinic-led initiatives
Case highlights the nuance of managing kidney disease in patients undergoing chemotherapy
The team reports their early experience and what's ahead
Assessing surgical approaches while identifying new ones
First in-human-trial for diagnostic bladder disorder device
Information on the microbiome and urologic pathologies remain relatively limited
Advertisement
Advertisement